Post-Market Clinical Follow-Up of STRATAFIX™ Spiral PDS™ PLUS

Inclusion Criteria

• Inclusion: 1. Elect to have a Robotic Bariatric Sleeve Gastrectomy or Robotic Total Hysterectomy where STRATAFIX™ Spiral PDS™ Plus device is used for staple line re-enforcement or vaginal cuff closure, respectively 2. Are willing and able to give consent and comply with all study-related evaluations and treatment scheduled 3. Subjects are ≥ 18 years of age Exclusion: 1. Physical or psychological condition which would impair study participation or are unwilling or unable to participate in all required study visits 2. Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of study product 3. Enrolled in a concurrent clinical study (drug/device) that might affect current study primary or secondary endpoints 4. Allergic to poly (p-dioxanon), IRGACARE®* MP (triclosan) or D&C Violet No. 2 colorant 5. Pregnant or lactating female subjects as confirmed prior to the procedure 6. Subjects undergoing radical hysterectomy (Type B, C and D) according to Querleu & Morrow classification or gastric sleeve revision surgery